Challenger shares jumped 19.3% to A$11.75 on Monday 19 October 2026, closing just 5 cents below a A$11.80 a share takeover proposal from TAL Dai-ichi Life Australia. The bidder, part of Japan’s Dai-ichi Life Group, already owns about a fifth of the annuities giant and now wants the rest.
What Dai-ichi Life has offered
According to Challenger’s ASX announcement, received after the market closed on Friday 16 October:
- Price: A$11.80 cash per share
- Target: the remaining 79.5% of Challenger that the Dai-ichi group does not already own
- Structure: a scheme of arrangement
- Premium: 17.7% to Challenger’s one-month volume-weighted average price of A$10.03, and 19.8% to Friday’s close of A$9.85
Reuters reported the offer values Challenger at about A$7.9 billion.
The proposal is non-binding. It is subject to due diligence, a scheme implementation agreement, regulatory approvals and a board recommendation. Challenger’s board is considering the offer and said there is no certainty it will result in a binding deal.
The insider angle: a 20% holder moves for control
This is not a bid from a stranger. Dai-ichi Life bought a 15.1% stake in Challenger from Japan’s MS&AD Insurance Group in April 2025 and has since lifted it to about 20%, according to Reuters.
When a major shareholder makes a takeover bid, it usually knows the business well. That can make a deal more likely, but it also puts the spotlight on whether the price is high enough for the other 79.5% of shareholders.
Challenger was buying back its own shares below A$10
Challenger has been buying back its own shares on market since 1 October. Its latest buy-back notice shows:
- 500,000 shares bought on Friday 16 October at A$9.69 to A$9.89
- 3,456,020 shares bought in total for about A$34.0 million, an average of about A$9.84
That means the company was buying stock about 20% below the bid price on the same day the proposal arrived. Our Maas Group buy-back report explains why buy-back notices are worth tracking.
A strong first quarter
Challenger also released its September quarter update on Monday. Total sales rose 52% to A$4.4 billion, annuity sales jumped 72% to A$2.8 billion, and Challenger’s assets under management rose 5% to A$31.9 billion.
Why the price gap matters
With shares at A$11.75, the market is pricing in a high chance of a deal at A$11.80 or better. Similar to the Cleanaway takeover, the next step is whether the bidder completes due diligence and signs a binding agreement.
What Challenger investors should watch
- The board’s response, including whether it grants due diligence
- A binding scheme agreement and any change in price
- Substantial holder notices from Dai-ichi or other funds
- Regulatory approvals for the deal
Bottom line
Dai-ichi Life is using its 20% stake as a springboard to bid for all of Challenger at A$11.80 a share. With shares trading just below the offer, investors are betting a deal gets done.
